Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LITFULO safely and effectively. See full prescribing information for LITFULO. LITFULO™ (ritlecitinib) capsules, for oral use Initial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
LITFULO is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older. Limitations of Use: Not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine or other potent immunosuppressants.
- generic_name
- ritlecitinib
- product_names
- ritlecitinib
- ndc
- 0069-0334, 0069-0334-28
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en